Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02608476 · ClinicalTrials.gov registry record · Phase 3
A Study to Evaluate the Safety and Efficacy of CB-03-01 Cream, 1% in Subjects With Facial Acne Vulgaris (26)
A Phase 3 study, sponsored by Cassiopea SpA.
- Completed
- Registry status
- Phase 3
- Development phase
- 732
- Enrollment target
NCT02608476 is a Phase 3 study that has completed, run by Cassiopea SpA. The registered enrollment target is 732 participants.
The verdict
NCT02608476, a Phase 3 study, has completed, sponsored by Cassiopea SpA.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 732 participants
- Enrollment target
Study Summary
The primary objective of this study is to determine the safety and efficacy of CB-03-01 cream, 1%, versus the vehicle cream applied twice daily for 12 weeks in subjects with facial acne vulgaris.
Interventions
- DRUG Vehicle cream
- DRUG CB-03-01 cream, 1%
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 732 participants |
| Start Date | 2015-11-16 |
| Est. Completion | 2018-02-21 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02608476
The ClinicalTrials.gov registry entry for NCT02608476 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 732 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cassiopea SpA, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Vehicle cream is the first listed.
NCT02608476 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02608476 about?
NCT02608476 is a clinical study titled "A Study to Evaluate the Safety and Efficacy of CB-03-01 Cream, 1% in Subjects With Facial Acne Vulgaris (26)". The primary objective of this study is to determine the safety and efficacy of CB-03-01 cream, 1%, versus the vehicle cream applied twice daily for 12 weeks in subjects with facial acne vulgaris.
What is the current status of trial NCT02608476?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 732 participants. The study started on 2015-11-16. Estimated completion is 2018-02-21.
What interventions are being tested in trial NCT02608476?
The interventions under investigation include: Vehicle cream (DRUG), CB-03-01 cream, 1% (DRUG).
Who is sponsoring clinical trial NCT02608476?
This trial is sponsored by Cassiopea SpA, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.